Finance

Lists
DARE:NASDAQ
Dare Bioscience Inc
0,69 US$
+0,29%
(+0,0020) 1D
0,68 US$
-1,96% (-0,014)
After hours
Closed: 11 ნოე, 16:00:00 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for DARE...
Open
0,71 US$
High
0,72 US$
Low
0,69 US$
Mkt. cap
13,65 მლნ.
Avg. vol.
145,35 ათ.
Volume
0,00
52-wk high
3,78 US$
52-wk low
0,61 US$
EPS
-0,79 US$
Beta
1,11
Shares outstanding
19,67 მლნ.
No. of employees
21
Open
0,71 US$
High
0,72 US$
Low
0,69 US$
Mkt. cap
13,65 მლნ.
Avg. vol.
145,35 ათ.
Volume
0,00
52-wk high
3,78 US$
52-wk low
0,61 US$
EPS
-0,79 US$
Beta
1,11
Shares outstanding
19,67 მლნ.
No. of employees
21
News stories
From web sources and news partners
About Dare Bioscience Inc
CEOსაბრინა მარტუჩი ჯონსონ
Employees21
Founded2005
Headquartersსან-დიეგო, კალიფორნია, ამერიკის შეერთებული შტატები
SectorHealth Care
IndustryPharmaceutical industry
Websitedarebioscience.com
Analyst ratings
Based on 3 analysts giving stock ratings to DARE in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for DARE in the last 3 months.
Highest
Current 0,69 US$
12,00 US$ (+1 628,86%)
Average
7,33 US$ (+956,04%)
Lowest
2,00 US$ (+188,14%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jeffrey Cohen
Ladenburg Thalmann & Co.
Buy
Initiated
2,00 US$
+188,1%
10/26/2026
Douglas Tsao
H.C. Wainwright
Buy
Reiterated
12,00 US$
+1 628,9%
09/21/2026
Jason McCarthy
Maxim Group
Buy
Maintained
8,00 US$
+1 052,6%
08/14/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
სექ. 2025
დეკ. 2025
მარ. 2026
ივნ. 2026
Revenue
2,26 ათ.
1,02 მლნ.
152,46 ათ.
187,55 ათ.
Cost of goods sold
1,18 მლნ.
-4,61 მლნ.
902,79 ათ.
561,86 ათ.
Cost of revenue
1,18 მლნ.
-4,61 მლნ.
902,79 ათ.
561,86 ათ.
Research and development expenses
-
5,52 მლნ.
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2,50 მლნ.
1,58 მლნ.
2,25 მლნ.
2,59 მლნ.
Operating expense
2,50 მლნ.
7,10 მლნ.
2,25 მლნ.
2,59 მლნ.
Total operating expenses
3,67 მლნ.
2,49 მლნ.
3,15 მლნ.
3,16 მლნ.
Operating income
-3,67 მლნ.
-1,47 მლნ.
-3,00 მლნ.
-2,97 მლნ.
Other non operating income
109,38 ათ.
29,55 ათ.
-991,00
-14,79 ათ.
EBT including unusual items
-3,56 მლნ.
-1,44 მლნ.
-3,00 მლნ.
-2,98 მლნ.
EBT excluding unusual items
-3,56 მლნ.
-1,44 მლნ.
-3,00 მლნ.
-2,98 მლნ.
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-3,56 მლნ.
-1,44 მლნ.
-3,00 მლნ.
-2,98 მლნ.
Net profit margin
-157 505,13%
-140,84%
-1 967,72%
-1 590,42%
Earnings per share
-0,28
-0,10
-0,20
-0,20
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-3,19 მლნ.
-936,87 ათ.
-2,44 მლნ.
-2,40 მლნ.
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google აპები